parenteral administration of butyrate ( 500 mg/kg/day ) for ten days to a child with acute myelogenous leukemia in relapse , and resistant to conventional therapy , resulted in elimination of myeloblasts from the peripheral blood , an increase in mature myeloid cells and a reduction in 3h-thymidine uptake by the patient 's peripheral blood cells .
C0229664
peripheral blood
C0005773
peripheral blood cells